Skip to main content
Year archive

Luye Pharma Group Limited — 2018 filings

All 134 regulatory filings released by Luye Pharma Group Limited (2186) in 2018, sourced directly from the official regulator.

134 Filings
2018 Period
2018 filings (134)
Filing Released Lang
Terms of Reference for Nomination Committee of the board of directors of the Company
Governance Information
2018-12-28 English
Terms of Reference for the Audit Committee of the board of directors of the Company
Governance Information
2018-12-28 English
Next Day Disclosure Return
Transaction in Own Shares
2018-12-27 English
CONNECTED TRANSACTION - IN RELATION TO THE ACQUISITION OF BIOLOGICAL ANTIBODY DRUGS LY01011 AND LY09004
Capital/Financing Update
2018-12-20 English
INSIDE INFORMATION ANNOUNCEMENT UPDATE ON LISTING STATUS
Delisting Announcement
2018-12-13 English
VOLUNTARY ANNOUNCEMENT - ROTIGOTINE EXTENDED RELEASE MICROSPHERES FOR INJECTION (LY03003)APPLICATION FOR CLINICAL TRIAL IN JAPAN
Regulatory Filings
2018-12-11 English
DISCLOSEABLE TRANSACTION DISPOSAL OF A SUBSIDIARY
Capital/Financing Update
2018-12-07 English
Interim Report 2018
Interim / Quarterly Report H1 2018
2018-12-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2018
Regulatory Filings
2018-12-04 English
CLARIFICATION ANNOUNCEMENT
Regulatory Filings
2018-12-04 English
INSIDE INFORMATION ANNOUNCEMENT - UPDATE ON LISTING STATUS
Delisting Announcement
2018-12-03 English
FURTHER DELAY IN DESPATCH OF CIRCULAR IN RELATION TO MAJOR TRANSACTION REGARDING ACQUISITION OF 60% EQUITY INTERESTS IN THE TARGET COMPANY
Regulatory Filings
2018-12-03 English
Monthly Return of Equity Issuer on Movements in Securities
Capital/Financing Update
2018-12-03 English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2018
Interim / Quarterly Report H1 2018
2018-11-29 English
List of Directors and their Roles and Functions
Board/Management Information
2018-11-20 English
VACATION OF OFFICE OF AN EXECUTIVE DIRECTOR AND CHANGE OF COMPOSITION OF THE REMUNERATION COMMITTEE
Board/Management Information
2018-11-20 English
DATE OF BOARD MEETING
Regulatory Filings
2018-11-19 English
PROFIT WARNING
Regulatory Filings
2018-11-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2018
Share Issue/Capital Change
2018-11-05 English
UNAUDITED FINANCIAL INFORMATION OF YANTAI LUYE
Capital/Financing Update
2018-11-01 English
Monthly Return of Equity Issuer on Movements in Securities
Capital/Financing Update
2018-11-01 English
FURTHER DELAY IN DESPATCH OF CIRCULAR IN RELATION TO MAJOR TRANSACTION REGARDING ACQUISITION OF 60% EQUITY INTERESTS IN THE TARGET COMPANY
Report Publication Announcement
2018-10-31 English
List of Directors and their Roles and Functions
Board/Management Information
2018-10-25 English
ANNOUNCEMENT - (1) RESIGNATION OF DIRECTORS&#x3b;(2) CHANGE OF CHAIRMAN AND CHIEF EXECUTIVE OFFICER&#x3b;(3) APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTORS&#x3b;(4) CHANGE IN COMPOSITION OF BOARD
Board/Management Information
2018-10-25 English
JOINT ANNOUNCEMENT - (1) CLOSE OF MANDATORY UNCONDITIONAL CASH OFFER BY OPTIMA CAPITAL LIMITED ON BEHALF OF ALWAYS PROFIT DEVELOPMENT LIMITED TO ACQUIRE ALL THE ISSUED SHARES IN STATE ENERGY GROUP IN
M&A Activity
2018-10-25 English
Next Day Disclosure Return
Transaction in Own Shares
2018-10-11 English
INSIDE INFORMATION ANNOUNCEMENT UPDATE ON LISTING STATUS
Delisting Announcement
2018-10-11 English
PROFIT FORECAST UNDER RULE 10 OF THE TAKEOVERS CODE
Regulatory Filings
2018-10-11 English
JOINT ANNOUNCEMENT DESPATCH OF RESPONSE DOCUMENT AND REVISED EXPECTED TIMETABLE IN RELATION TO THE MANDATORY UNCONDITIONAL CASH OFFER BY OPTIMA CAPITAL LIMITED ON BEHALF OF ALWAYS PROFIT DEVELOPM
M&A Activity
2018-10-11 English
RESPONSE DOCUMENT IN RELATION TO MANDATORY UNCONDITIONAL CASH OFFER BY OPTIMA CAPITAL LIMITED ON BEHALF OF ALWAYS PROFIT DEVELOPMENT LIMITED TO ACQUIRE ALL THE ISSUED SHARES IN STATE ENERGY GROUP INT
M&A Activity
2018-10-11 English
JOINT ANNOUNCEMENT - FURTHER DELAY IN DESPATCH OF RESPONSE DOCUMENT AND EXTENSION OF CLOSING DATE RELATING TO THE MANDATORY UNCONDITIONAL CASH OFFER
Regulatory Filings
2018-10-05 English
VOLUNTARY ANNOUNCEMENT - UNABLE TO CONTACT AN EXECUTIVE DIRECTOR
Board/Management Information
2018-10-05 English
INSIDE INFORMATION ANNOUNCEMENT UPDATE ON LISTING STATUS
Delisting Announcement
2018-10-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2018
Share Issue/Capital Change
2018-10-02 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2018-10-02 English
FURTHER DELAY IN DESPATCH OF CIRCULAR IN RELATION TO MAJOR TRANSACTION ACQUISITION OF 60% EQUITY INTERESTS IN THE TARGET COMPANY
Regulatory Filings
2018-09-28 English
Interim Report 2018
Interim / Quarterly Report H1 2018
2018-09-28 English
List of Directors and their Roles and Functions
Board/Management Information
2018-09-27 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 27 SEPTEMBER 2018 AND RE-APPOINTMENT OF DIRECTORS
Declaration of Voting Results & Voting Rights Announcements
2018-09-27 English
VOLUNTARY ANNOUNCEMENT - APPROVAL FROM FDA FOR CLINICAL TRIAL FOR LY03010
Regulatory Filings
2018-09-26 English
JOINT ANNOUNCEMENT DELAY IN DESPATCH OF RESPONSE DOCUMENT AND EXTENSION OF CLOSING DATE RELATING TO THE MANDATORY UNCONDITIONAL CASH OFFER
Regulatory Filings
2018-09-24 English
SUPPLEMENTAL ANNOUNCEMENT - DECISION OF THE REVIEW HEARING OF THE LISTING COMMITTEE
Delisting Announcement
2018-09-19 English
INSIDE INFORMATION ANNOUNCEMENT - FURTHER ANNOUNCEMENT ON THE STOCK EXCHANGE'S NOTICE TO SUSPEND TRADING IN THE COMPANY'S SHARES AND PLACE THE COMPANY IN THE FIRST DELISTING STAGE
Delisting Announcement
2018-09-18 English
VOLUNTARY ANNOUNCEMENT - REGISTRATION APPLICATION OF RIVASTIGMINE TRANSDERMAL PATCH ACCEPTED BY CHINA NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Regulatory Filings
2018-09-17 English
List of Directors and their Roles and Functions
Board/Management Information
2018-09-12 English
APPOINTMENT OF DIRECTORS
Board/Management Information
2018-09-12 English
FORM OF ACCEPTANCE AND TRANSFER OF ORDINARY SHARE(S) OF HK$0.1 EACH IN THE ISSUED SHARE CAPITAL OF STATE ENERGY GROUP INTERNATIONAL ASSETS HOLDINGS LIMITED
Merger & Acquisition
2018-09-10 English
MANDATORY UNCONDITIONAL CASH OFFER BY OPTIMA CAPITAL LIMITED ON BEHALF OF ALWAYS PROFIT DEVELOPMENT LIMITED TO ACQUIRE ALL THE ISSUED SHARES IN STATE ENERGY GROUP INTERNATIONAL ASSETS HOLDINGS LIMITE
M&A Activity
2018-09-10 English
ANNOUNCEMENT - DESPATCH OF THE OFFER DOCUMENT RELATING TO MANDATORY UNCONDITIONAL CASH OFFER BY OPTIMA CAPITAL LIMITED ON BEHALF OF ALWAYS PROFIT DEVELOPMENT LIMITED TO ACQUIRE ALL THE ISSUED SHARES
M&A Activity
2018-09-10 English
Appointment of Independent Financial Adviser
Regulatory Filings
2018-09-07 English
Next Day Disclosure Return
Transaction in Own Shares
2018-09-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2018
Share Issue/Capital Change
2018-09-05 English
VOLUNTARY ANNOUNCEMENT - GOSERELIN ACETATE EXTENDED-RELEASE MICROSPHERES FOR INJECTION (LY01005) COMMENCED PHASE III CLINICAL TRIAL IN CHINA
Regulatory Filings
2018-09-04 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2018-09-03 English
VOLUNTARY ANNOUNCEMENT - CLASS 1.1 NEW CHEMICAL DRUG LY03012 APPROVED FOR CLINICAL TRIAL IN CHINA
Regulatory Filings
2018-09-03 English
DELAY IN DESPATCH OF CIRCULAR IN RELATION TO MAJOR TRANSACTION ACQUISITION OF 60% EQUITY INTERESTS IN THE TARGET COMPANY
Regulatory Filings
2018-08-31 English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2017/18
Environmental & Social Information
2018-08-31 English
EXCHANGE NOTICE - RESUMPTION OF TRADING
Regulatory Filings
2018-08-30 English
ANNOUNCEMENT PURSUANT TO RULE 3.2 OF THE TAKEOVERS CODE IN RELATION TO THE MANDATORY UNCONDITIONAL CASH OFFER AND RESUMPTION OF TRADING
M&A Activity
2018-08-29 English
(1) ACQUISITION OF SHARES IN STATE ENERGY GROUP INTERNATIONAL ASSETS HOLDINGS LIMITED BY ALWAYS PROFIT DEVELOPMENT LIMITED&#x3b; AND (2) MANDATORY UNCONDITIONAL CASH OFFER BY OPTIMA CAPITAL LIMITED O
M&A Activity
2018-08-29 English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2018
Interim / Quarterly Report H1 2018
2018-08-26 English
EXCHANGE NOTICE - TRADING HALT
Regulatory Filings
2018-08-23 English
TRADING HALT
M&A Activity
2018-08-23 English
NOTICE OF BOARD MEETING
Regulatory Filings
2018-08-15 English
VOLUNTARY ANNOUNCEMENT - ACQUISITION OF BAYER'S GLOBAL RIGHTS TO APLEEK
M&A Activity
2018-08-06 English
CHANGE OF INFORMATION OF DIRECTOR
Board/Management Information
2018-08-03 English
ANNOUNCEMENT MADE PURSUANT TO RULE 13.18 OF THE LISTING RULES
Capital/Financing Update
2018-08-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2018
Share Issue/Capital Change
2018-08-02 English
Monthly Return of Equity Issuer on Movements in Securities
Capital/Financing Update
2018-08-01 English
VOLUNTARY ANNOUNCEMENT - APPROVAL FOR CLINICAL TRIAL FOR CLASS I NEW CHEMICAL DRUG - ANTI-TUMOR INNOVATIVE DRUG (LY01013) IN CHINA
Regulatory Filings
2018-07-31 English
Form of proxy for use by shareholders at the Annual General Meeting to be convened on 27 September 2018 at 3:00 p.m.
AGM Information
2018-07-30 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2018-07-30 English
GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES&#x3b; RE-ELECTION OF DIRECTORS&#x3b; AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2018-07-30 English
Annual Report 2017/18
Annual Report FY 2018
2018-07-30 English
Environmental, Social and Governance Report 2017
Environmental & Social Information
2018-07-25 English
VOLUNTARY ANNOUNCEMENT - APPROVAL OF NEW INDICATION FOR SEROQUEL XR IN CHINA
Regulatory Filings
2018-07-19 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2018
Regulatory Filings
2018-07-04 English
Monthly Return of Equity Issuer on Movements in Securities
Capital/Financing Update
2018-07-04 English
ANNOUNCEMENT OF FINAL RESULTS FOR THE YEAR ENDED 31 MARCH 2018
Annual Report FY 2018
2018-06-28 English
MAJOR TRANSACTION IN RELATION TO ACQUISITION OF ASTRAZENECA'S RIGHTS RELATING TO SEROQUEL AND SEROQUEL XR IN CHINA AND IN OTHER TERRITORIES
M&A Activity
2018-06-28 English
MAJOR TRANSACTION ACQUISITION OF 60% EQUITY INTERESTS IN THE TARGET COMPANY
M&A Activity
2018-06-28 English
POLL RESULTS OF SPECIAL GENERAL MEETING HELD ON 22 JUNE 2018
Declaration of Voting Results & Voting Rights Announcements
2018-06-22 English
ANNOUNCEMENT MADE PURSUANT TO RULE 13.18 OF THE LISTING RULES
Capital/Financing Update
2018-06-22 English
VOLUNTARY ANNOUNCEMENT - ROTIGOTINE EXTENDED RELEASE MICROSPHERES FOR INJECTION (LY03003) COMMENCED PHASE III CLINICAL TRIAL IN CHINA
Regulatory Filings
2018-06-20 English
INSIDE INFORMATION ANNOUNCEMENT - REQUEST FOR REVIEW OF THE FIRST DELISTING STAGE DECISION
Delisting Announcement
2018-06-15 English
CLINICAL APPLICATION OF CLASS 1.1 NEW CHEMICAL DRUG LY03012 WAS FORMALLY ACCEPTED
Regulatory Filings
2018-06-15 English
DATE OF BOARD MEETING
Report Publication Announcement
2018-06-14 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 11 JUNE 2018
Declaration of Voting Results & Voting Rights Announcements
2018-06-11 English
VOLUNTARY ANNOUNCEMENT - ANSOFAXINE HYDROCHLORIDE EXTENDED RELEASE TABLETS (LY03005) COMMENCED PHASE III CLINICAL TRIAL IN CHINA
Regulatory Filings
2018-06-11 English
INSIDE INFORMATION ANNOUNCEMENT AND ANNOUNCEMENT PURSUANT TO RULE 13.24A OF THE LISTING RULES
Delisting Announcement
2018-06-11 English
CHANGE OF BOOK CLOSURE PERIOD
Notice of Dividend Amount
2018-06-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2018
Capital/Financing Update
2018-06-06 English
PROXY FORM FOR SPECIAL GENERAL MEETING
Proxy Solicitation & Information Statement
2018-06-05 English
NOTICE OF THE SPECIAL GENERAL MEETING
Proxy Solicitation & Information Statement
2018-06-05 English
MAJOR TRANSACTION - ACQUISITION OF ASTRAZENECA'S RIGHTS RELATING TO SEROQUEL AND SEROQUEL XR IN CHINA AND IN OTHER TERRITORIES AND NOTICE OF SPECIAL GENERAL MEETING
Proxy Solicitation & Information Statement
2018-06-05 English
ACQUISITION OF ASTRAZENECA'S RIGHTS RELATING TO SEROQUEL AND SEROQUEL XR IN CHINA AND IN OTHER TERRITORIES MAJOR TRANSACTION
Regulatory Filings
2018-06-05 English
Monthly Return of Equity Issuer on Movements in Securities
Capital/Financing Update
2018-06-01 English
List of Directors and their Roles and Functions
Board/Management Information
2018-05-29 English
APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHAIRMAN OF AUDIT COMMITTEE
Board/Management Information
2018-05-29 English
ANNOUNCEMENT - CAR-T THERAPY DEVELOPMENT COLLABORATION WITH ELPIS BIOPHARM
Regulatory Filings
2018-05-28 English
POSITIVE PROFIT ALERT
Regulatory Filings
2018-05-18 English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING TO BE HELD ON 11 JUNE 2018
AGM Information
2018-05-09 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2018-05-09 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2018-05-09 English
DISCLOSEABLE TRANSACTION IN RELATION TO ACQUISITION OF ASTRAZENECA'S RIGHTS RELATING TO SEROQUEL AND SEROQUEL XR IN CHINA AND IN OTHER TERRITORIES
Capital/Financing Update
2018-05-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2018
Regulatory Filings
2018-05-07 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2018-05-02 English
UNAUDITED FINANCIAL INFORMATION OF YANTAI LUYE
Capital/Financing Update
2018-05-02 English
Annual Report 2017
Regulatory Filings
2018-04-27 English
ANNOUNCEMENT
Regulatory Filings
2018-04-25 English
List of Directors and their Roles and Functions
Governance Information
2018-04-23 English
RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR
Board/Management Information
2018-04-23 English
VOLUNTARY ANNOUNCEMENT - APPROVAL FOR ROTIGOTINE EXTENDED RELEASE MICROSPHERES FOR INJECTION FROM PHASE III CLINICAL TRIALS IN CHINA
Regulatory Filings
2018-04-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2018
Share Issue/Capital Change
2018-04-04 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2018-04-04 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2017
Annual Report FY 2017
2018-03-26 English
VOLUNTARY ANNOUNCEMENT - IMMUNO-ONCOLOGY ANTIBODY DRUG DEVELOPMENT COLLABORATION WITH EXCEL BIOPHARM
Regulatory Filings
2018-03-21 English
Next Day Disclosure Return
Share Issue/Capital Change
2018-03-20 English
NOTICE OF BOARD MEETING
Regulatory Filings
2018-03-12 English
VOLUNTARY ANNOUNCEMENT - ROTIGOTINE EXTENDED RELEASE MICROSPHERES FOR INJECTION EXEMPTED FROM PHASE II CLINICAL TRIALS IN CHINA
Regulatory Filings
2018-03-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2018
Regulatory Filings
2018-03-06 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2018-03-01 English
VOLUNTARY ANNOUNCEMENT - CFDA OFFICIALLY ACCEPTED OUR CLINICAL TRIAL APPLICATION FOR CLASS I NEW CHEMICAL DRUG - ANTI-TUMOR INNOVATIVE DRUG LY01013
Regulatory Filings
2018-02-26 English
VOLUNTARY ANNOUNCEMENT - FDA AGREES TO WAIVE PEDIATRIC CLINICAL TRIALS OF LY03004
Regulatory Filings
2018-02-21 English
CHARGE OF SHARES BY CONTROLLING SHAREHOLDER
Major Shareholding Notification
2018-02-13 English
VOLUNTARY ANNOUNCEMENT - ROTIGOTINE EXTENDED RELEASE MICROSPHERES FOR INJECTION EXEMPTED FROM PHASE II CLINICAL TRIALS IN THE UNITED STATES
Capital/Financing Update
2018-02-08 English
BUSINESS UPDATE
Capital/Financing Update
2018-02-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2018
Share Issue/Capital Change
2018-02-05 English
List of Directors and their Roles and Functions
Board/Management Information
2018-02-01 English
(1) RESIGNATION OF EXECUTIVE DIRECTOR AND CHAIRMAN&#x3b; AND (2) APPOINTMENT OF CHAIRMAN
Board/Management Information
2018-02-01 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2018-02-01 English
VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL IN CHINA FOR ANSOFAXINE HYDROCHLORIDE EXTENDED RELEASE TABLETS (LY03005) SHOWED POSITIVE RESULTS
Regulatory Filings
2018-01-23 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2017
Share Issue/Capital Change
2018-01-04 English
Monthly Return of Equity Issuer on Movements in Securities
Capital/Financing Update
2018-01-02 English